Blood pressure fluctuation and hypertension in patients with Parkinson's disease

Brain and Behavior
Tetsuro TsukamotoSadako Kuno

Abstract

Blood pressure (BP) abnormalities have been known in Parkinson's disease (PD) patients. The present study aimed at determining how the BPs of PD patients fluctuate in a day. A total of 37 PD patients and 44 OD (other disease) patients, all of who were inpatients, were monitored every 30 min by 24-h ambulatory blood pressure monitoring (ABPM). The average systolic BP and the number of patients who showed postprandial hypotension were not different between the two groups. However, occurrence of nocturnal hypertension, BP fluctuation of over 100 mmHg in a day and BP of over 200 mmHg were significantly more frequently observed in the PD patients than in the OD patients. In the PD patients, these parameters were not different between those who were suffering from the disease for less than 10 years and those with the disease for 10 years or longer, as well as between those who had a Hoehn-Yahr staging scale of 2-3 and those with a scale of 4-5. Twenty-four-hour ABPM, not BP measurement once a day, enables us to determine the actual BP in PD patients. Although hypotension is a severe risk factor for falling and syncope, we emphasize the importance of monitoring rather hypertension and fluctuating BP in PD patients that may lead to a v...Continue Reading

References

Apr 1, 1992·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·J M SenardJ L Montastruc
Jan 22, 1972·Lancet·M GrossR Godwin-Austen
Jul 14, 1999·Journal of Hypertension·J M MallionR De Gaudemaris
Jun 11, 2002·Blood Pressure Monitoring·G Parati, G Mancia
Sep 12, 2006·European Journal of Internal Medicine·A Ahsan EjazSandeep Munjal
Sep 11, 2009·Journal of the Neurological Sciences·Tjalf Ziemssen, Heinz Reichmann
Sep 22, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Claudia SchmidtTjalf Ziemssen
Mar 3, 2010·The American Journal of Medicine·Gina L LucianoMichael B Rothberg
May 12, 2010·Archives of Neurology·Adam M BrickmanRichard Mayeux
Sep 21, 2010·Parkinsonism & Related Disorders·Samay Jain
Jul 19, 2011·Journal of the Neurological Sciences·Yehonatan Sharabi, David S Goldstein
Sep 4, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Masato AsahinaChristopher J Mathias
May 31, 2013·Frontiers in Neurology·Eva StuebnerCarl-Albrecht Haensch
Jul 17, 2013·Nature Reviews. Neurology·Shin-ichiro Kubo, Nobutaka Hattori

❮ Previous
Next ❯

Citations

Jun 6, 2014·Herz·A Athanasiadis, U Sechtem
Mar 19, 2014·Journal of the American Medical Directors Association·Laurence G TrahairKaren L Jones
May 28, 2015·Postgraduate Medicine·Louis KuritzkyEric Dietrich
Oct 24, 2017·Neurological Research·Jesús Piqueras-FloresAlfonso Jurado-Román
Dec 12, 2017·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Joanne DiFrancisco-DonoghueAdena Leder
Feb 6, 2018·Clinical and Experimental Hypertension : CHE·Yanli ZhuLin Ye
Feb 20, 2018·Journal of Clinical Movement Disorders·David E Riley, Alberto J Espay
Sep 30, 2020·Metabolic Brain Disease·Jesús D Meléndez-Flores, Ingrid Estrada-Bellmann
Mar 23, 2017·Physiological Reports·Chiho Sumi-IchinoseKazunao Kondo
Sep 13, 2017·Frontiers in Neuroscience·Tumul ChowdhuryRonald B Cappellani
Feb 6, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Jessica J SteventonKevin Murphy
May 21, 2019·Journal of Hypertension·Antonio R ZamunérRaffaello Furlan
Mar 1, 2017·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Artur FedorowskiWouter Wieling
Nov 2, 2017·Translational Neurodegeneration·Panchanan MaitiGary L Dunbar
Aug 21, 2018·Pharmacological Reports : PR·Hosein PasandiAbolfazl Khajavirad
Apr 5, 2018·Frontiers in Neurology·Liyan HouQingshan Wang
Dec 20, 2018·International Journal of Molecular Sciences·Federica De LazzariFederica Sandrelli
Oct 8, 2020·Expert Opinion on Pharmacotherapy·Fulvio A ScorzaJosef Finsterer
Sep 1, 2018·Pharmacological Reports : PR·Hosein PasandiAbolfazl Khajavirad
Apr 10, 2021·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O V Guseva, N G Zhukova
Apr 20, 2021·Parkinson's Disease·Zimple KurlawalaRobert P Friedland
May 8, 2021·Current Hypertension Reports·Vasiliki KatsiKonstantinos Tsioufis
Jun 3, 2021·International Journal of Environmental Research and Public Health·Patrícia LyraJoão Botelho

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Jennifer E FlytheSteven M Brunelli
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Ville PursiainenVilho V Myllylä
Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue européenne pour les sciences médicales et pharmacologiques
P Pasqualetti, R Casale
© 2021 Meta ULC. All rights reserved